162 related articles for article (PubMed ID: 16095849)
1. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
[TBL] [Abstract][Full Text] [Related]
2. [Genetic risk after high dose radioiodine therapy with regard to gonadal dose].
Ehrenheim C; Hauswirth C; Fitschen J; Martin E; Oetting G; Hundeshagen H
Nuklearmedizin; 1997 Aug; 36(5):157-66. PubMed ID: 9380527
[TBL] [Abstract][Full Text] [Related]
3. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer.
Sarkar SD; Beierwaltes WH; Gill SP; Cowley BJ
J Nucl Med; 1976 Jun; 17(6):460-4. PubMed ID: 944243
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients.
Maxon HR; Englaro EE; Thomas SR; Hertzberg VS; Hinnefeld JD; Chen LS; Smith H; Cummings D; Aden MD
J Nucl Med; 1992 Jun; 33(6):1132-6. PubMed ID: 1597728
[TBL] [Abstract][Full Text] [Related]
5. Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine.
Pacini F; Gasperi M; Fugazzola L; Ceccarelli C; Lippi F; Centoni R; Martino E; Pinchera A
J Nucl Med; 1994 Sep; 35(9):1418-22. PubMed ID: 8071685
[TBL] [Abstract][Full Text] [Related]
6. 131I therapy of thyroid cancer patients.
Reiners C; Farahati J
Q J Nucl Med; 1999 Dec; 43(4):324-35. PubMed ID: 10731783
[TBL] [Abstract][Full Text] [Related]
7. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma.
Dottorini ME; Lomuscio G; Mazzucchelli L; Vignati A; Colombo L
J Nucl Med; 1995 Jan; 36(1):21-7. PubMed ID: 7799075
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine therapy during an unknown remained pregnancy and radiation exposure of the fetus. A case report.
Arndt D; Mehnert WH; Franke WG; Woller P; Laude G; Rockel A; Waller M
Strahlenther Onkol; 1994 Jul; 170(7):408-14. PubMed ID: 8052940
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the plan of therapy on prognosis in thyroid cancer].
Schümichen C; Schmitt E; Scheuffele C; Blattmann H; Pauli-Harnasch C
Nuklearmedizin; 1983 Apr; 22(2):97-105. PubMed ID: 6866782
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine and radiotherapy in the management of thyroid cancers.
Simpson WJ
Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
[TBL] [Abstract][Full Text] [Related]
11. Improved prediction of therapeutic absorbed doses of radioiodine in the treatment of thyroid carcinoma.
Hermanská J; Kárný M; Zimák J; Jirsa L; Sámal M; Vlcek P
J Nucl Med; 2001 Jul; 42(7):1084-90. PubMed ID: 11438632
[TBL] [Abstract][Full Text] [Related]
12. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
[TBL] [Abstract][Full Text] [Related]
13. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer.
Vini L; Hyer S; Al-Saadi A; Pratt B; Harmer C
Postgrad Med J; 2002 Feb; 78(916):92-3. PubMed ID: 11807191
[TBL] [Abstract][Full Text] [Related]
14. [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid].
Kaniewski M; Czetwertyńska M; Godlewska P; Drac-Kaniewska J
Wiad Lek; 2001; 54 Suppl 1():297-300. PubMed ID: 12182038
[TBL] [Abstract][Full Text] [Related]
15. Testicular dose and fertility in men following I(131) therapy for thyroid cancer.
Hyer S; Vini L; O'Connell M; Pratt B; Harmer C
Clin Endocrinol (Oxf); 2002 Jun; 56(6):755-8. PubMed ID: 12072044
[TBL] [Abstract][Full Text] [Related]
16. Differentiated thyroid carcinoma in childhood.
Travagli JP; Schlumberger M; De Vathaire F; Francese C; Parmentier C
J Endocrinol Invest; 1995 Feb; 18(2):161-4. PubMed ID: 7629389
[No Abstract] [Full Text] [Related]
17. [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].
Baranauskas ZL; Mamontov VV; Valutskas KK
Med Radiol (Mosk); 1989 Oct; 34(10):31-4. PubMed ID: 2811625
[TBL] [Abstract][Full Text] [Related]
18. High-dose radiation and the emergence of thyroid nodular disease.
Rosen IB; Simpson JA; Sutcliffe S; Gorenstein L
Surgery; 1984 Dec; 96(6):988-95. PubMed ID: 6505971
[TBL] [Abstract][Full Text] [Related]
19. Subsequent malignancies in patients treated with 131-iodine for thyroid cancer.
Glanzmann C
Strahlenther Onkol; 1992 Jun; 168(6):337-43. PubMed ID: 1621212
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine treatment of hyperthyroidism in a pregnant women.
Berg GE; Nyström EH; Jacobsson L; Lindberg S; Lindstedt RG; Mattsson S; Niklasson CA; Norén AH; Westphal OG
J Nucl Med; 1998 Feb; 39(2):357-61. PubMed ID: 9476950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]